| 000 | 01435 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511201715.0 | ||
| 264 | 0 | _c19910828 | |
| 008 | 199108s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/bjc.1991.258 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRichel, D J | |
| 245 | 0 | 0 |
_aThe antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJul 1991 |
||
| 300 |
_a144-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmsacrine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntigens, CD _xanalysis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAzacitidine _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow _xpathology |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aColly, L P | |
| 700 | 1 | _aKluin-Nelemans, J C | |
| 700 | 1 | _aWillemze, R | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 64 _gno. 1 _gp. 144-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1991.258 _zAvailable from publisher's website |
| 999 |
_c1719450 _d1719450 |
||